Neogen Corporation Proceeds from (Repayments of) Other Long-term Debt
Neogen Corporation (NEOG) reported Proceeds from (Repayments of) Other Long-term Debt of $0 for the 6-month period ending 2015-11-30, per its 10-Q filed 2016-01-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt · last filed 2016-01-08
- Neogen Corporation proceeds from (repayments of) other long-term debt for the quarter ending 2015-11-30 was $0.00.
- Neogen Corporation proceeds from (repayments of) other long-term debt for the quarter ending 2015-08-31 was $0.00.
- Neogen Corporation proceeds from (repayments of) other long-term debt for the quarter ending 2015-05-31 was $0.00.
- Neogen Corporation proceeds from (repayments of) other long-term debt for the quarter ending 2015-02-28 was $0.00, a 100.00% decline year-over-year.
- Neogen Corporation proceeds from (repayments of) other long-term debt for fiscal 2015 was $0.00.
- Neogen Corporation proceeds from (repayments of) other long-term debt for fiscal 2014 was $0.00.
- Neogen Corporation proceeds from (repayments of) other long-term debt for fiscal 2013 was -$155.00K.
- Neogen Corporation proceeds from (repayments of) other long-term debt for fiscal 2012 was -$750.00K.
| Period end | Proceeds from (Repayments of) Other Long-term Debt 3 month | Proceeds from (Repayments of) Other Long-term Debt 6 month | Proceeds from (Repayments of) Other Long-term Debt 9 month | Proceeds from (Repayments of) Other Long-term Debt 12 month |
|---|---|---|---|---|
| 2015-11-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-01-08 | $0.00 10-Q · filed 2016-01-08 | $0.00 derived: sum of 3 quarters · filed 2016-01-08 | $0.00 derived: sum of 4 quarters · filed 2016-01-08 |
| 2015-08-31 | $0.00 10-Q · filed 2015-09-30 | $0.00 derived: sum of 2 quarters · filed 2015-09-30 | $0.00 derived: sum of 3 quarters · filed 2015-09-30 | $0.00 derived: sum of 4 quarters · filed 2016-01-08 |
| 2015-05-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-30 | $0.00 derived: sum of 2 quarters · filed 2015-07-30 | $0.00 derived: sum of 3 quarters · filed 2016-01-08 | $0.00 10-K · filed 2015-07-30 |
| 2015-02-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-01 | $0.00 derived: sum of 2 quarters · filed 2016-01-08 | $0.00 10-Q · filed 2015-04-01 | -$168.00K derived: sum of 4 quarters · filed 2016-01-08 |
| 2014-11-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-01-08 | $0.00 10-Q · filed 2016-01-08 | -$168.00K derived: sum of 3 quarters · filed 2016-01-08 | -$110.00K derived: sum of 4 quarters · filed 2016-01-08 |
| 2014-08-31 | $0.00 10-Q · filed 2015-09-30 | -$168.00K derived: sum of 2 quarters · filed 2015-09-30 | -$110.00K derived: sum of 3 quarters · filed 2015-09-30 | -$56.00K derived: sum of 4 quarters · filed 2015-09-30 |
| 2014-05-31 | -$168.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-30 | -$110.00K derived: sum of 2 quarters · filed 2015-07-30 | -$56.00K derived: sum of 3 quarters · filed 2015-07-30 | $0.00 10-K · filed 2015-07-30 |
| 2014-02-28 | $58.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-01 | $112.00K derived: sum of 2 quarters · filed 2015-04-01 | $168.00K 10-Q · filed 2015-04-01 | $100.00K derived: sum of 4 quarters · filed 2015-07-30 |
| 2013-11-30 | $54.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-12-30 | $110.00K 10-Q · filed 2014-12-30 | $42.00K derived: sum of 3 quarters · filed 2015-07-30 | $45.00K derived: sum of 4 quarters · filed 2015-07-30 |
| 2013-08-31 | $56.00K 10-Q · filed 2014-09-30 | -$12.00K derived: sum of 2 quarters · filed 2015-07-30 | -$9.00K derived: sum of 3 quarters · filed 2015-07-30 | $188.00K derived: sum of 4 quarters · filed 2015-07-30 |
| 2013-05-31 | -$68.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-30 | -$65.00K derived: sum of 2 quarters · filed 2015-07-30 | $132.00K derived: sum of 3 quarters · filed 2015-07-30 | -$155.00K 10-K · filed 2015-07-30 |
| 2013-02-28 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-04-04 | $200.00K derived: sum of 2 quarters · filed 2014-04-04 | -$87.00K 10-Q · filed 2014-04-04 | -$87.00K derived: sum of 4 quarters · filed 2014-07-30 |
| 2012-11-30 | $197.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-01-09 | -$90.00K 10-Q · filed 2014-01-09 | -$90.00K derived: sum of 3 quarters · filed 2014-07-30 | $14.00K derived: sum of 4 quarters · filed 2014-07-30 |
| 2012-08-31 | -$287.00K 10-Q · filed 2013-09-30 | -$287.00K derived: sum of 2 quarters · filed 2014-07-30 | -$183.00K derived: sum of 3 quarters · filed 2014-07-30 | -$951.00K derived: sum of 4 quarters · filed 2014-07-30 |
| 2012-05-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-30 | $104.00K derived: sum of 2 quarters · filed 2014-07-30 | -$664.00K derived: sum of 3 quarters · filed 2014-07-30 | -$750.00K 10-K · filed 2014-07-30 |
| 2012-02-29 | $104.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-03-28 | -$664.00K derived: sum of 2 quarters · filed 2013-03-28 | -$750.00K 10-Q · filed 2013-03-28 | |
| 2011-11-30 | -$768.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-12-28 | -$854.00K 10-Q · filed 2012-12-28 | ||
| 2011-08-31 | -$86.00K 10-Q · filed 2012-09-28 | |||
| 2011-05-31 | -$1.22M 10-K · filed 2013-07-30 | |||
| 2010-05-31 | $100.00K 10-K · filed 2012-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |